Cadavid Diego
Insider CIK 1778713 · XFOR Chief Medical Officer · FULC See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-03-01 | 2022-03-01 | 97,000 | — | $0 | 104,107 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | S Sale | 2022-02-11 | 2022-02-14 | 928 | — | $0 | 7,107 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2021-03-24 | 2021-03-25 | 8,035 | — | $0 | 8,035 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-12-31 | 2021-01-06 | 121,500 | $6.43 | $781.2K | 121,500 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-07-01 | 2020-07-02 | 1,071 | $18.30 | $19.6K | 65,714 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-06-25 | 2020-06-26 | 1,459 | — | $0 | 12,277 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-06-25 | 2020-06-26 | 1,459 | $4.83 | $7.0K | 68,244 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-25 | 2020-06-26 | 1,459 | $22.00 | $32.1K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-06-10 | 2020-06-12 | 401 | — | $0 | 13,736 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-10 | 2020-06-12 | 401 | $22.00 | $8.8K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-06-10 | 2020-06-12 | 401 | $4.83 | $1.9K | 67,186 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-06-05 | 2020-06-08 | 451 | — | $0 | 14,137 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-06-05 | 2020-06-08 | 451 | $4.83 | $2.2K | 67,236 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-05 | 2020-06-08 | 451 | $20.18 | $9.1K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-06-04 | 2020-06-08 | 226 | — | $0 | 14,588 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-04 | 2020-06-08 | 226 | $20.05 | $4.5K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-06-04 | 2020-06-08 | 226 | $4.83 | $1.1K | 67,011 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-06-03 | 2020-06-04 | 338 | — | $0 | 14,814 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-06-03 | 2020-06-04 | 338 | $4.83 | $1.6K | 67,123 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-03 | 2020-06-04 | 338 | $20.18 | $6.8K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-06-02 | 2020-06-04 | 45 | — | $0 | 15,152 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-06-02 | 2020-06-04 | 45 | $4.83 | $217 | 66,830 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-02 | 2020-06-04 | 45 | $20.00 | $900 | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-05-29 | 2020-06-01 | 200 | — | $0 | 15,197 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-29 | 2020-06-01 | 200 | $20.04 | $4.0K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-05-29 | 2020-06-01 | 200 | $4.83 | $966 | 66,985 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-05-28 | 2020-06-01 | 600 | — | $0 | 15,397 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-05-28 | 2020-06-01 | 600 | $4.83 | $2.9K | 67,385 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-28 | 2020-06-01 | 600 | $20.00 | $12.0K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2020-05-12 | 2020-05-12 | 1,860 | — | $0 | 15,997 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-12 | 2020-05-12 | 1,860 | $18.00 | $33.5K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2020-05-12 | 2020-05-12 | 1,860 | $4.83 | $9.0K | 68,645 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-03-02 | 2020-03-02 | 315 | $18.13 | $5.7K | 66,785 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-03-02 | 2020-03-02 | 1,828 | $17.26 | $31.6K | 67,100 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-02-03 | 2020-02-05 | 2,143 | $17.33 | $37.1K | 68,928 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2020-01-23 | 2020-01-27 | 55,440 | — | $0 | 55,440 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2019-07-18 | 2019-07-18 | 12,784 | — | $0 | 12,784 | SEC↗ |